Patient Stories     Committee     Documents

About

Welcome!
I am pleased to introduce you to the brand new UK molecular radiotherapy consortium.
We are an enthusiastic group comprised of both healthcare professionals and patient advocates who are directly and passionately associated in delivering and caring for patients undergoing molecular radiotherapy based treatments.
We are here first and foremost to serve current and future patients who may find the need to receive such types of treatment to help maintain and sustain both quality and duration of life.

What is Molecular Radiotherapy (MRT)?

This is when either atoms or molecules which emit radiation are used to facilitate the death of cancer cells.

For over the past 80 years, radioisotope based therapies such as radioiodine has played an extremely important part in successfully treating patients with thyroid cancers, made possible by the specific properties of thyroid gland, requiring absorption of Iodine for routine function.
Due to its success, it is understandable and indeed desirable to find similar targeted radioisotope therapy that may benefit thousands of other patients with different types of cancer and over this time as our understanding of cancer, it’s associated micro environment (what is happening immediately around the cancer cells in the body) including over expression of specific tumour associated extra cellular markers has become better understood, more complex radioisotope treatments have been developed.
We have now reached the dawn of an era whereby many thousands of patients will benefit from such treatment spanning across multiple cancer sites. However, across the UK we find inadequate infrastructure, training and specialised healthcare professionals to be able to cope with the burgeoning demands placed by these developments; therefore the UK molecular radiotherapy consortium has become the forum to help advise NHS England, develop nationally agreed protocols with an aspiration to lead on molecular radiation based research and become a world leader moving delivery and molecular radiotherapy trial design over the next decade.
By bringing members and fellows of both the British Nuclear Medicine Society and the Royal College of Radiologists together along with patient advocates and nationally recognised charities, we will endeavour to ensure that all parts of the United Kingdom will have equitable access to current and future therapies, raise public awareness of such treatments, design and encourage activity in nationally recognised molecular radiotherapy trials.

Please feel free to reach out…..View the Committee members list here